83 related articles for article (PubMed ID: 1299984)
1. [Role of pharmacovigilance center in information for the public on drugs. Experience in Marseille on 9 month].
Jean-Pastor MJ; Morange-Sala S; Rodor F; Gambini D; Galland MC; David JM; Jouglard J
Therapie; 1992; 47(5):429-32. PubMed ID: 1299984
[TBL] [Abstract][Full Text] [Related]
2. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
Mey C; Hentschel H; Hippius M; Balogh A
Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
[TBL] [Abstract][Full Text] [Related]
3. [Pharmacovigilance of antibiotics. Evaluation by the Midi-Pyrénées Pharmacovigilance Center between 1989 and 1992].
Llau ME; Damase-Michel C; Lapeyre-Mestre M; Vie M; Rascol O
Therapie; 1994; 49(2):123-7. PubMed ID: 7817335
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of drug and poison information center in Saudi Arabia during the period 2000-2002.
Asiri YA; Al-Arifi MN; Al-Sultan MS; Gubara OA
Saudi Med J; 2007 Apr; 28(4):617-9. PubMed ID: 17457489
[TBL] [Abstract][Full Text] [Related]
5. The nature of the scientific evidence leading to drug withdrawals for pharmacovigilance reasons in France.
Olivier P; Montastruc JL
Pharmacoepidemiol Drug Saf; 2006 Nov; 15(11):808-12. PubMed ID: 16700082
[TBL] [Abstract][Full Text] [Related]
6. Poison Information Service of the Nofer Institute of Occupational Medicine in Lódź. Types of toxicological inquiries 1991-1994.
Jaraczewska W; Czerczak S; Kotwica M; Fabicka B
Int J Occup Med Environ Health; 1997; 10(2):167-75. PubMed ID: 9278129
[TBL] [Abstract][Full Text] [Related]
7. [Retrospective study of adverse drug reactions in the elderly: experience of regional center for pharmacovigilance].
Bruneau S; Bruhat C; Lagarce L; Lainé-Cessac P
Therapie; 2001; 56(6):785-91. PubMed ID: 11878111
[TBL] [Abstract][Full Text] [Related]
8. The need for drug and poison information--the Singapore physicians' perspective.
Ponampalam R; Anantharaman V
Singapore Med J; 2003 May; 44(5):231-42. PubMed ID: 13677359
[TBL] [Abstract][Full Text] [Related]
9. Adverse drug reactions in patients older than 70 years during the heat wave occurred in France in summer 2003: A study from the French PharmacoVigilance Database.
Michenot F; Sommet A; Bagheri H; Lapeyre-Mestre M; Montastruc JL;
Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):735-40. PubMed ID: 16924603
[TBL] [Abstract][Full Text] [Related]
10. Survey of consumer users of a statewide drug information service.
Smith GH; Einarson TR
Am J Hosp Pharm; 1985 Jul; 42(7):1557-61. PubMed ID: 4025353
[TBL] [Abstract][Full Text] [Related]
11. Short communication: pattern of adverse drug reaction related queries received by the drug information centre of a tertiary care teaching hospital.
Jimmy B; Jose J; Rao PG
Pak J Pharm Sci; 2007 Oct; 20(4):333-9. PubMed ID: 17604259
[TBL] [Abstract][Full Text] [Related]
12. 19th French pharmacovigilance meeting. Health professionals and consumers are inadequately informed.
Prescrire Int; 1998 Dec; 7(38):188-90. PubMed ID: 10848054
[TBL] [Abstract][Full Text] [Related]
13. Utilization of a community pharmacy-operated national drug information call center in Finland.
Pohjanoksa-Mäntylä MK; Antila J; Eerikäinen S; Enäkoski M; Hannuksela O; Pietilä K; Airaksinen M
Res Social Adm Pharm; 2008 Jun; 4(2):144-52. PubMed ID: 18555967
[TBL] [Abstract][Full Text] [Related]
14. [Users of a regional center of pharmacovigilance].
Haramburu F; Abraham E; Bégaud B
Therapie; 1993; 48(5):475-7. PubMed ID: 8146828
[TBL] [Abstract][Full Text] [Related]
15. Contribution of the regional drug information center towards drug safety.
Palaian S; Mishra P; Shankar PR; Bista D; Purwar B
JNMA J Nepal Med Assoc; 2006; 45(161):216-8. PubMed ID: 17160101
[TBL] [Abstract][Full Text] [Related]
16. [Inventory of questions posed at a Regional Pharmacovigilance Center. Discussion about a possible coordination of informatics].
Carlier P; Lagier G; Castot A; Bidault I
Therapie; 1990; 45(5):383-6. PubMed ID: 2260029
[TBL] [Abstract][Full Text] [Related]
17. 9-1-1 implementation: implications for poison center access.
Grant-Willey ME; Burton BT; Wanke LA; Saunders JA
Vet Hum Toxicol; 1985 Dec; 27(6):536-9. PubMed ID: 4082472
[TBL] [Abstract][Full Text] [Related]
18. Analysis of initial requests for information of non-exposure related topics at a regional poison center.
Winter JP; Hornfeldt CS; Weiland MJ; Ling LJ
Vet Hum Toxicol; 1988 Apr; 30(2):108-9. PubMed ID: 3381478
[TBL] [Abstract][Full Text] [Related]
19. Adverse drug reaction monitoring and the Internet: evaluation of the use of the Internet by French Pharmacovigilance Centres and a non-exhaustive survey of websites of interest for collecting information about adverse drug reaction.
Morel P; Vandel B
Therapie; 1999; 54(5):525-32. PubMed ID: 10667084
[TBL] [Abstract][Full Text] [Related]
20. Increasing burden of pill identification requests to US Poison Centers.
Spiller HA; Griffith JR
Clin Toxicol (Phila); 2009 Mar; 47(3):253-5. PubMed ID: 19225960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
